60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
0.9191
-0.0429 (-4.46%)
Dec 10, 2025, 12:10 PM EST - Market open
SXTP Stock Forecast
Stock Price Forecast
The 2 analysts that cover SXTP stock have a consensus rating of "Strong Buy" and an average price target of $4.40, which forecasts a 378.73% increase in the stock price over the next year. The lowest target is $2.80 and the highest is $6.00.
Price Target: $4.40 (+378.73%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SXTP stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $3 → $2.8 | Strong Buy | Maintains | $3 → $2.8 | +204.65% | Nov 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +552.81% | Nov 14, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $7 → $3 | Strong Buy | Maintains | $7 → $3 | +226.41% | Sep 3, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $5.8 → $7 | Strong Buy | Maintains | $5.8 → $7 | +661.61% | Jun 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Mar 28, 2025 |
Financial Forecast
Revenue This Year
1.68M
from 681.35K
Increased by 146.28%
Revenue Next Year
2.09M
from 1.68M
Increased by 24.61%
EPS This Year
-3.36
from -18.55
EPS Next Year
-1.76
from -3.36
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 1.9M | 2.5M | ||
| Avg | 1.7M | 2.1M | ||
| Low | 1.5M | 1.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 177.4% | 50.2% | ||
| Avg | 146.3% | 24.6% | ||
| Low | 114.3% | -0.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -3.35 | -1.55 | |
| Avg | -3.36 | -1.76 | |
| Low | -3.32 | -1.93 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.